Africa: Twice-Yearly HIV Prevention Shot Priced At  – – What It Means for South Africa

Africa: Twice-Yearly HIV Prevention Shot Priced At $40 – – What It Means for South Africa

What’s new From 2027, Indian generics companies and Hetero Labs Dr. Reddy’s will supply lenacapavir, a twice-yearly injectable PrEP with ~96-100% efficacy, for US$40 (R698) per person per year across 120 low- and middle-income countries. South Africa, home to the world’s largest HIV epidemic, is included in the agreement, making the country one of the…

Read More
Africa: Twice-Yearly HIV Prevention Shot Priced At  – – What It Means for South Africa

Africa: AU Chairperson Outlines Three-Point Plan to Boost Conflict Prevention in Africa

Addis Ababa — Chairperson of the African Union Commission, Mahmoud Ali Youssouf, addressed the AU Peace and Security Council on the sidelines of the 80th United Nations General Assembly (UNGA80) in New York on Wednesday, presenting a comprehensive strategy to address the continent’s security challenges. Youssouf expressed gratitude to Angolan President João Lourenço for convening…

Read More
Africa: Twice-Yearly HIV Prevention Shot Priced At  – – What It Means for South Africa

Nigeria: Breastfeeding Week 2025 – Empowering African Women By Integrating HIV Prevention Into the First Bonds of Life

Prudence Nonkululeko Ngwenya and Toyin Saraki (Guest writers) During the recently commemorated Pan-African Women’s Day (PAWD), we were reminded of the enduring legacy, resilience, and leadership of African women. However, as we celebrated, we also confronted a lingering truth: far too many pregnant and breastfeeding women in Africa are still left behind in HIV prevention…

Read More
Africa: Twice-Yearly HIV Prevention Shot Priced At  – – What It Means for South Africa

Africa: Empowering African Women From the Start – Integrating HIV Prevention Into the First Bonds of Life

Each year, Pan-African Women’s Day (PAWD) reminds us of the enduring legacy, resilience, and leadership of African women. However, as we celebrate, we must also confront a lingering truth: far too many pregnant and breastfeeding women in Africa are still left behind in HIV prevention efforts. Pregnant and breastfeeding women are not merely recipients of…

Read More
Payment trends and APP fraud prevention in the spotlight at ACI World Payments Intelligence Roadshow

Payment trends and APP fraud prevention in the spotlight at ACI World Payments Intelligence Roadshow

APP scam losses are on the rise, according to ACI Worldwide’s latest Scamscope report. Amid an ever-changing payments landscape, real-time payments are booming, offering significant value for financial institutions. At the same time, Authorized Push Payment (APP) scam losses are on the rise. To unpack these and other key trends in payments and fraud prevention,…

Read More
Africa: Twice-Yearly HIV Prevention Shot Priced At  – – What It Means for South Africa

Africa: Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low – and Middle-Income Countries

Geneva — A pivotal moment in the fight to end AIDS — ensuring lifesaving innovation reaches those who need it most, wherever they live The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) today announced it has signed an access agreement with Gilead Sciences to procure lenacapavir, a long-acting injectable for HIV…

Read More